Seal Rock Therapeutics develops small molecule inhibitors targeting ASK1, a kinase involved in apoptosis and inflammation, to treat inflammatory and fibrotic conditions such as NASH. The company addresses the lack of approved therapies for liver and central nervous system diseases by providing first-in-class treatment options for patients with significant unmet medical needs.
Funding
$8.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many inflammatory and fibrotic diseases, such as NASH, lack effective treatments, leading to significant unmet medical needs for patients suffering from organ injury, inflammation, and fibrosis. Current therapeutic options are limited, highlighting the need for novel approaches to address these conditions.
Solution
Seal Rock Therapeutics develops small molecule inhibitors targeting Apoptosis Signal-regulating Kinase 1 (ASK1), a key kinase involved in apoptosis and inflammation pathways. By inhibiting ASK1, the company aims to modulate these pathways and treat inflammatory and fibrotic conditions. Their approach focuses on creating first-in-class kinase inhibitors to address diseases with limited treatment options, particularly liver and central nervous system diseases. The company's robust drug discovery platform identifies next-generation kinase inhibitors to target critical mechanisms of organ injury.
Target Audience
The primary target audience includes patients suffering from inflammatory and fibrotic conditions, particularly liver and central nervous system diseases, with a focus on those with limited treatment options and significant unmet medical needs.
Features
- Development of small molecule inhibitors targeting ASK1.
- Focus on inflammatory and fibrotic conditions, including NASH.
- Robust drug discovery platform for identifying next-generation kinase inhibitors.
- Targeting critical mechanisms of organ injury, inflammation, and fibrosis.